Estramustine
| Estramustine | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 440.40 g/mol [1] |
| Melting point | 155 [1] |
| Solubility | 3.85e-04 g/L [1] |
| Predicted LogP | 4 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C23H31Cl2NO3 |
| IUPAC name | [(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate |
| SMILES | C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl |
| InChI | InChI=1S/C23H31Cl2NO3/c1-23-9-8-18-17-5-3-16(29-22(28)26(12-10-24)13-11-25)14-15(17)2-4-19(18)20(23)6-7-21(23)27/h3,5,14,18-21,27H,2,4,6-13H2,1H3/t18-,19-,20+,21+,23+/m1/s1 |
| InChIKey | FRPJXPJMRWBBIH-RBRWEJTLSA-N |
| CAS number | 2998-57-4 |
| UNII | 35LT29625A |
| PubChem CID | 259331 |
Estramustine (also known as Estramustinum, Estramustina, Leo-275, Leo 275, Leo275, Estradiol 3-(N,N-bis(2-chloroethyl)carbamate), 17β-Estradiol 3-(bis(2-chloroethyl)carbamate), Estradiol 3-[bis(2-chloroethyl)carbamate], Ro 21-8837 or Ro 22-2296/000) is a substance of the phenol and steroid class.
Chemistry
Stereochemistry []
Estramustine is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Estramustine matches Lipinski's rule of five.Pharmacology
ATC Classification
- antineoplastic and immunomodulating agents (L)
- antineoplastic agents (L01)
- other antineoplastic agents (L01X)
- other antineoplastic agents (L01XX)
- (L01XX11)
- estramustine (L01XX11)
MeSH Classification
Mechanism of action []
Estramustine is a derivative of estradiol with a nitrogen mustard moiety. This gives it alkylating properties. In vivo, the nitrogen mustard component is active and can alklyate DNA and other cellular components (such as tubulin components) of rapidly dividing cells. This causes DNA strandbreaks or misscoding events. This leads to apoptosis and cell death. Also, due to the drugs estrogen component, it can bind more selectively to active estrogen receptors. [1]
Interactions []
Medical side effects []
66 side effects listed on drug labels in SIDER 4.1 (estramustine).
- Thrombocytopenia
- Congenital anomaly
- Developmental delay
- Alopecia
- Anaemia
- Angioedema
- Decreased appetite
- Anxiety
- Chest pain
- Confusional state
- Feeling abnormal
- Libido decreased
- Disturbance in sexual arousal
- Depression
- Diarrhoea
- Polyuria
- Dyspnoea
- Oedema
- Dermatitis
- Rash
- Flatulence
- Flushing
- Gastrointestinal haemorrhage
- Gynaecomastia
- Headache
- Cardiac arrest
- Cardiac failure congestive
- Dysphonia
- Hypercalcaemia
- Hypertension
- Muscle spasms
- Lethargy
- Leukopenia
- Myocardial infarction
- Acute coronary syndrome
- Nausea
- Night sweats
- Pruritus
- Cerebrovascular accident
- Thirst
- Embolism
- Embolism venous
- Thrombophlebitis
- Tinnitus
- Vomiting
- Mood swings
- Affect lability
- Myocardial ischaemia
- Muscular weakness
- Eye pain
- Dry skin
- Dyspepsia
- Gastrointestinal disorder
- Gastrointestinal symptom NOS
- Tenderness
- Skin exfoliation
- Fluid retention
- Lacrimation increased
- Increased tendency to bruise
- Transaminases increased
- Throat irritation
- Menopausal symptoms
- Hot flush
- Insomnia
- Abdominal discomfort
- Gastrointestinal tract irritation
Indications
- Neoplasm
- Prostate carcinoma
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 259331, Estramustine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/259331
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Estramustine. UNII: 35LT29625A. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/35LT29625A
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 06:29:40 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 06:29:36 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 06:29:36 |
| gsrs | ok | 2026-11-20 06:29:37 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0015327) | 2026-11-20 06:29:36 |
| kegg | ok | 2026-11-20 06:29:38 |
| pubchem | ok | 2026-11-20 06:29:36 |
| missing (no r/tripreports posts mention it) | 2026-11-20 06:29:36 | |
| sider | ok | 2026-11-20 06:29:36 |
| structure | ok | 2026-11-20 06:29:36 |
| wikipedia | ok | 2026-11-20 06:29:36 |